McKinsey, the consultancy firm, is nearing a deal with US prosecutors to pay at least $500 million to settle numerous probes into the firm’s past work with opioid makers

Adidas says it will raise prices on all its US products due to new tariffs

Pakistan Minister: India is planning an attack on Pakistan in 24-36 hours

After President Trump called Jeff Bezos, Amazon, AMZN, called off its plan to add ‘tariff price adjustments’ to product listings

Lutnick: All cars that are finished in US that have 85% domestic content will have no tariffs

Consulting firm McKinsey &amp; Co. is nearing a deal with U.S. prosecutors to pay at least $500 million to resolve federal investigations into its past work with opioid manufacturers, according to a report by Bloomberg News on Wednesday.The settlement, expected to be announced in the coming weeks, would settle both criminal and civil probes by the Justice Department, as reported by sources familiar with the situation. Federal prosecutors have been investigating McKinsey's involvement in the opioid crisis, focusing on its advisory role for Purdue Pharma, the maker of OxyContin, and other drug companies.The investigation is examining whether McKinsey engaged in criminal conspiracy by advising pharmaceutical companies on marketing strategies that contributed to the increased sales of prescription painkillers, which fueled widespread addiction and overdose deaths.McKinsey has already reached settlements totaling nearly $1 billion to resolve numerous opioid-related lawsuits. These agreements involve all 50 U.S. states, Washington, D.C., U.S. territories, local governments, school districts, Native American tribes, and health insurers.In 2019, McKinsey announced it would no longer advise clients on opioid-related matters. The company has maintained that none of the previous settlements include admissions of liability or wrongdoing.